Michael Gramlich

Auburn University
United States

Yu Kitago

United States

Samantha Bozarth

, United States

Laura Rosen

Acumen Pharmaceuticals
United States

PAPER Bhattacharya A, Shepherd C, El-Assaad F, Mather KA

Bacteria in the brain: do they have a role in the pathogenesis of Alzheimer's disease?

Curr Opin Psychiatry. 2025 May 1;38(3):252-257. Epub 2025 Feb 27 PubMed.

James Herndon

Emory University
United States

Cheng Hu

Technetium Therapeutics
United States

Xulin Li

, China

PAPER Hida M, Yasuda K, Toyokawa M, Asada-Utsugi M, Toda S, Yanagida N, Takahashi R, Kinoshita A, Maki T

Amyloidogenic and non-amyloidogenic pathways of amyloid precursor protein processing in oligodendrocytes.

Brain Res. 2025 Mar 26;1855:149601. Epub 2025 Mar 26 PubMed.

PAPER Braun A, Basson D, Moosa S, Carr J, Bardien S, van Coller R

Deep Brain Stimulation Improves Symptoms in an Individual with Alpha-Synuclein-Gene-Associated Parkinson's Disease.

Mov Disord Clin Pract. 2025 Mar 29; Epub 2025 Mar 29 PubMed.

PAPER Muir RT, Stukas S, Cooper JG, Beaudin AE, McCreary CR, Gee M, Nelles K, Nukala N, Valencia J, Kirmess KM, Black SE, Hill MD, Camicioli R, Wellington CL, Smith EE

Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls.

Alzheimers Dement. 2025 Mar;21(3):e70010. PubMed.

PAPER Rabinovici GD, Selkoe DJ, Schindler SE, Aisen P, Apostolova LG, Atri A, Greenberg SM, Hendrix SB, Petersen RC, Weiner M, Salloway S, Cummings J

Donanemab: Appropriate use recommendations.

J Prev Alzheimers Dis. 2025 Mar 27;:100150. Epub 2025 Mar 27 PubMed.

PAPER Donaghy PC, Hasoon J, Hamilton CA, Ciafone J, Durcan R, Barnett N, Olsen K, Lawley S, Greenfinch G, Firbank M, Heslegrave A, Zetterberg H, Allan L, O'Brien JT, Taylor JP, Thomas AJ

Plasma Biomarkers and Disease Prognosis in Mild Cognitive Impairment with Lewy Bodies.

Mov Disord. 2025 Mar 29; Epub 2025 Mar 29 PubMed.

PAPER Rehman H, Ang TF, Tao Q, Au R, Farrer LA, Qiu WQ, Zhang X, Alzheimer's Disease Neuroimaging Initiative

Plasma protein risk scores for mild cognitive impairment and Alzheimer's disease in the Framingham heart study.

Alzheimers Dement. 2025 Mar;21(3):e70066. PubMed.

PAPER Ribino P, Di Napoli C, Paragliola G, Chicco D, Gasparini F

Multivariate longitudinal clustering reveals neuropsychological factors as dementia predictors in an Alzheimer's disease progression study.

BioData Min. 2025 Mar 28;18(1):26. PubMed.